Hyloris Pharmaceuticals SA (HYL.BR)

EUR 5.83

(0.34%)

Revenue Summary of Hyloris Pharmaceuticals SA

Hyloris Pharmaceuticals SA's latest annual revenue in 2023 was 2.08 Million EUR , down -29.28% from previous year.
Hyloris Pharmaceuticals SA's latest quarterly revenue in 2023 FY was 2.08 Million EUR , down -29.28% from previous quarter.
Hyloris Pharmaceuticals SA reported a annual revenue of 2.95 Million EUR in annual revenue 2022, down -4.68% from previous year.
Hyloris Pharmaceuticals SA reported a annual revenue of 3.09 Million EUR in annual revenue 2021, up 1669.14% from previous year.
Hyloris Pharmaceuticals SA reported a quarterly revenue of 1.52 Million EUR for 2023 Q3, up 163.28% from previous quarter.
Hyloris Pharmaceuticals SA reported a quarterly revenue of 580 Thousand EUR for 2023 Q1, down -14.33% from previous quarter.

Annual Revenue Chart of Hyloris Pharmaceuticals SA (2023 - 2017)

Historical Annual Revenue of Hyloris Pharmaceuticals SA (2023 - 2017)

Year	Revenue	Revenue Growth
2023	2.08 Million EUR	-29.28%
2022	2.95 Million EUR	-4.68%
2021	3.09 Million EUR	1669.14%
2020	175 Thousand EUR	92.31%
2019	91 Thousand EUR	0.0%
2018	91 Thousand EUR	-57.28%
2017	213 Thousand EUR	0.0%

Year	Revenue	Revenue Growth
2023 Q2	580 Thousand EUR	0.0%
2023 Q3	1.52 Million EUR	163.28%
2023 Q1	580 Thousand EUR	-14.33%
2023 FY	2.08 Million EUR	-29.28%
2023 Q4	1.52 Million EUR	0.0%
2022 Q2	1.03 Million EUR	100.0%
2022 FY	2.95 Million EUR	-4.68%
2022 Q4	677 Thousand EUR	0.0%
2022 Q3	677 Thousand EUR	-34.46%
2022 Q1	516.49 Thousand EUR	-77.13%
2021 FY	3.09 Million EUR	1669.14%
2021 Q4	2.25 Million EUR	100.0%
2021 Q3	1.12 Million EUR	34.73%
2021 Q2	838 Thousand EUR	100.0%
2021 Q1	419 Thousand EUR	801.08%
2020 Q2	19 Thousand EUR	-69.84%
2020 FY	175 Thousand EUR	92.31%
2020 Q4	46.5 Thousand EUR	0.0%
2020 Q1	63 Thousand EUR	687.5%
2020 Q3	46.5 Thousand EUR	144.74%
2019 Q2	35 Thousand EUR	-12.5%
2019 Q3	8000.00 EUR	-77.14%
2019 Q1	40 Thousand EUR	0.0%
2019 FY	91 Thousand EUR	0.0%
2019 Q4	8000.00 EUR	0.0%
2018 FY	91 Thousand EUR	-57.28%
2017 FY	213 Thousand EUR	0.0%

Peer Revenue Comparison of Hyloris Pharmaceuticals SA

Name	Revenue	Revenue Difference
Nicox S.A.	257 Thousand EUR	-712.062%
European Medical Solutions	40.56 Million EUR	94.855%
FERMENTALG	4.05 Million EUR	48.558%
argenx SE	1.13 Billion EUR	99.816%
BioSenic S.A.	543 Thousand EUR	-284.346%
Celyad Oncology SA	102 Thousand EUR	-1946.078%
Onward Medical N.V.	532 Thousand EUR	-292.293%
Oxurion NV	263 Thousand EUR	-693.536%
PHAXIAM Therapeutics S.A.	1.32 Million EUR	-57.391%
Financière de Tubize SA	- EUR	-Infinity%
UCB SA	5.25 Billion EUR	99.96%